Differences in CD33 intensity between various myeloid neoplasms. [electronic resource]
Producer: 20021024Description: 560-6 p. digitalISSN:- 0002-9173
- Aminoglycosides
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antigens, CD -- analysis
- Antigens, Differentiation, Myelomonocytic -- analysis
- Antineoplastic Agents -- therapeutic use
- Bone Marrow Cells -- immunology
- Flow Cytometry
- Gemtuzumab
- Humans
- Immunophenotyping
- Immunotoxins
- Leukemia -- drug therapy
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Prospective Studies
- Reproducibility of Results
- Sialic Acid Binding Ig-like Lectin 3
- Single-Blind Method
- Survival Analysis
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.